7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OL
7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OL Basic information
- Product Name:
- 7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OL
- Synonyms:
-
- OTAVA-BB BB7010150234
- 7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OL
- AKOS BBS-00001111
- AURORA 23227
- 7-(1-piperidinylmethyl)-8-hydroxyquinoline
- 8-Quinolinol, 7-(1-piperidinylmethyl)-
- NSC57969 >=98% (HPLC)
- CAS:
- 6632-09-3
- MF:
- C15H18N2O
- MW:
- 242.32
- Mol File:
- Mol File
7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OL Chemical Properties
- Melting point:
- 194 °C
- Boiling point:
- 402.4±30.0 °C(Predicted)
- Density
- 1.202±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: 5mg/mL, clear (warmed)
- pka
- 3.81±0.50(Predicted)
- form
- powder
- color
- white to beige
7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OL Usage And Synthesis
Uses
NSC-57969 is a multidrug resistant (MDR)-selective agent, exhibiting a robust Pgp-dependent toxic activity across diverse cancer cell lines[1].
Biological Activity
NSC57969 is a MDR-selective compound th at exhibits a robust Pgp-dependent toxic activity across diverse cancer cell lines. NSC57969 shows profound toxicity against doxorubicin resistant Brca1-/-;p53-/- spontaneous mouse mammary carcinoma cells. NSC57969 eradicates P-glycoprotein expression in doxorubicin resistant brca1-/-;p53-/- spontaneous mouse mammary carcinoma, and MES-SA/Dx5 cells. However treatment of normal cells (hCMEC/D3 cells) with NSC57969 does not induce loss of Pgp.
References
[1] András Füredi, et al. Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line-Specific Effects from P-Glycoprotein-Induced Toxicity. Mol Cancer Ther. 2017 Jan;16(1):45-56. DOI:10.1158/1535-7163.MCT-16-0333-T
7-(PIPERIDIN-1-YLMETHYL)QUINOLIN-8-OLSupplier
- Tel
- +86-021-50935922
- Tel
- 021-58432009 400-005-6266
- marketing@energy-chemical.com
- Tel
- 21-20338288
- ordercn@merckgroup.com
- Tel
- 51288865780
- sales@biosynth.com
- Tel
- +1-781-999-5354;
- support@targetmol.com